Humanwell pharmaceutical potassium chloride powder has been approved by FDA!

On November 27, humanwell pharmaceutical announced that its wholly-owned subsidiary epic Pharma has received the approval number of FDA for potassium chloride powder, which means that epic Pharma can produce and sell the product in the U.S market Potassium chloride powder is used to treat hypokalemia caused by various reasons, such as insufficient food, vomiting, severe diarrhea, application of potassium excreting diuretics, hypokalemic familial periodic paralysis, long-term application of glucocorticoids and hyperosmotic glucose supplement Epicpharma submitted an anda application for potassium chloride powder in 2017, with a cumulative R & D investment of about $700000 According to IMS data statistics, the total sales volume of potassium chloride powder in the U.S market in 2017 is about US $100 million, and the main manufacturers include Novartis, virtus Pharma, endo Pharma, etc At present, there is no product of the same dosage form in China In 2017, the sales volume of all dosage forms of potassium chloride in the three terminal public hospitals of cities, counties and towns in China was about 700 million yuan The main manufacturers include China Otsuka Pharmaceutical Co., Ltd., Hubei Kelun Pharmaceutical Co., Ltd., Guangzhou Yudong Health Pharmaceutical Co., Ltd., etc The specific announcement is as follows: